Literature DB >> 9349948

Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

H J Van Schaik1, B Heintz, M Larsen, E Leite, V Rosas, R Schalnus, J A Van Best.   

Abstract

BACKGROUND: The aim of this study was to compare the inward permeability of the blood-retinal barrier in healthy subjects from six European cities.
METHODS: Seventy-two healthy subjects (age 20-70 years) were selected. At 30 min and 60 min after fluorescein injection, fluorescein mass in vitreous was calculated from the concentrations measured along the optical axis of the eye. Non-protein-bound fluorescein (NPBF) concentrations were measured in plasma prepared from blood samples taken 7, 15 and 55 min after injection. Blood-retinal barrier permeability (PBRB) was calculated from the vitreous fluorescein mass and the time integral of NPBF and was corrected for the autofluorescence of ocular tissue and for lenticular light transmittance.
RESULTS: Mean PBRB values +/- SD (nm.s-1) were 2.07 +/- 0.54 (Coimbra), 2.01 +/- 0.43 (Frankfurt), 2.24 +/- 0.50 (Ghent), 2.37 +/- 0.56 (Herlev), 1.89 +/- 0.44 (Leiden) and 1.74 +/- 0.38 (Porto). Differences between centers were not significant (P > 0.35). Measurements were reproducible and independent of the time after fluorescein injection (P > 0.50). A PBRB higher than 3.16 nm.s-1 or a value which had increased by 32% was considered abnormal (P < 0.05).
CONCLUSION: PBRB values were similar in all centers. The results demonstrate that this is a highly sensitive and reliable method for measuring the permeability of the blood-retinal barrier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349948     DOI: 10.1007/bf00946940

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  42 in total

1.  Inward permeability of the blood-retinal barrier by fluorophotometry.

Authors:  J P Kappelhof; J A van Best; P L van Valenberg; J A Oosterhuis
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-04       Impact factor: 4.799

2.  [Fluorophotometry of changes of hemato-ocular barriers in intermediate uveitis].

Authors:  E Baglivo; E Bloch-Michel; B Ducot; M Offret; H Offret
Journal:  J Fr Ophtalmol       Date:  1995       Impact factor: 0.818

3.  Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.

Authors:  M S Roy; P M Bungay; R F Bonner
Journal:  Arch Ophthalmol       Date:  1989-09

4.  An 18-month vitreous fluorophotometric follow-up study in juvenile diabetics.

Authors:  J M Benitez del Castillo; A Castillo; J Garcia Sanchez; J L Ruibal; F Reverte; J M Ibarra
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-10

5.  Blood-retinal and blood-aqueous barrier permeability, lens autofluorescence and transmission in insulin-dependent diabetic youngsters.

Authors:  E van Wirdum; J van Best; G J Bruining; C de Beaufort; J Oosterhuis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

6.  The blood-retinal barrier in diabetes during puberty.

Authors:  J R de Abreu; R Silva; J G Cunha-Vaz
Journal:  Arch Ophthalmol       Date:  1994-10

7.  Long-term effects of topically applied epinephrine on the blood-ocular barrier in humans.

Authors:  K Miyake; Y Miyake; R Kuratomi
Journal:  Arch Ophthalmol       Date:  1987-10

8.  The blood-retinal barrier in chloroquine retinopathy.

Authors:  M F Raines; S K Bhargava; E S Rosen
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-08       Impact factor: 4.799

9.  Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.

Authors:  T W Gardner; A W Eller; T R Friberg; J A D'Antonio; T M Hollis
Journal:  Retina       Date:  1995       Impact factor: 4.256

10.  Fluorophotometric study of lens autofluorescence and the blood-retinal barrier in 56 diabetic patients.

Authors:  B Bordat; C Arnaud; I R Guirguis; A Laudeho
Journal:  Eur J Ophthalmol       Date:  1995 Jan-Mar       Impact factor: 1.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.